In consonance with proteomics, HTN-T2DM could promote the inhibition of glycolysis and gluconeogenesis (z-score = −3.3) and the PDH complex (z-score = −2.2), which may affect the TCA cycle (z-score = −4.1) (Table 2). This evidence concerns the gene PDP1 and type 2 diabetes mellitus.